Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,519,642
+$7,054,542 QoQ
Shares Held
377,130
+20.1% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#89
of 751 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 6%
Shared 16%
None 78%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cerity Partners LLC holds $424,897,823 across 139 Biotechnology names. EXEL ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
255,874 | $127,100,291 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
797,119 | $69,309,495 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
343,589 | $26,892,710 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
39,274 | $24,488,909 | |
| 5 | INCY |
Incyte Corp
|
205,071 | $23,246,847 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
377,130 | $20,519,642 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
53,534 | $12,900,087 | |
| 8 | RPRX |
Royalty Pharma plc
|
180,772 | $10,135,884 |
All Filings in EXEL
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,519,642 | 377,130 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,465,100 | 313,945 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,306,135 | 349,216 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $7,521,308 | 182,114 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $6,493,821 | 147,319 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,199,421 | 167,915 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $2,460,337 | 73,884 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $726,444 | 27,994 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $274,515 | 12,217 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $519,046 | 21,873 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||